Androstenedione (Adione)
| Order Code: | ANDRO1 |
| Epic Lab Code: | LAB518 |
| Order Form: | A-1a Miscellaneous Request or Epic Req |
Commercial Mail-out Laboratory
01250 PFP
356-3527
01250 PFP
356-3527
Specimen:
Serum
Collection Medium:
![]() |
| Red top tube |
Minimum:
Preferred Minimum: 1.0 mL serum
Absolute Minimum: 0.6 mL serum
Rejection Criteria:
Samples collected in SST tubes
Turn Around
Time:
5 days upon receipt at reference laboratory
Reference Range:
Androstenedione, LC/MS/MS (UOM ng/dL)
Adult Male Reference Ranges for Androstenedione, Serum:
18-30 years: 50-220 ng/dL
31-50 years: 40-190 ng/dL
51-60 years: 50-220 ng/dL
Adult Female Reference Ranges for Androstenedione, Serum:
Follicular Phase: 35-250 ng/dL
Luteal Phase: 30-235 ng/dL
Postmenopausal Phase: 20-75 ng/dL
Pediatric Reference Ranges for Androstenedione, Serum:
1-12 months**: 6-78 ng/dL
1-4 years**: 5-51 ng/dL
5-9 years: 6-115 ng/dL
10-13 years: 12-221 ng/dL
14-17 years: 22-225 ng/dL
Premature infants**: < or = 480 ng/dL
(31-35 weeks)
Term infants**: < or = 290 ng/dL
Tanner Stages**
II-III Males: 17-82 ng/dL
II-III Females: 43-180 ng/dL
IV-V Males: 57-150 ng/dL
IV-V Females: 73-220 ng/dL
**Pediatric data from J Clin Endocrinol Metab.
1991;73:674-686 and J Clin Endocrinol Metab.
1989;69;113-1136.
NOTE: Please understand the adult female reference range changes, effective 1/24/2011.
Adult Male Reference Ranges for Androstenedione, Serum:
18-30 years: 50-220 ng/dL
31-50 years: 40-190 ng/dL
51-60 years: 50-220 ng/dL
Adult Female Reference Ranges for Androstenedione, Serum:
Follicular Phase: 35-250 ng/dL
Luteal Phase: 30-235 ng/dL
Postmenopausal Phase: 20-75 ng/dL
Pediatric Reference Ranges for Androstenedione, Serum:
1-12 months**: 6-78 ng/dL
1-4 years**: 5-51 ng/dL
5-9 years: 6-115 ng/dL
10-13 years: 12-221 ng/dL
14-17 years: 22-225 ng/dL
Premature infants**: < or = 480 ng/dL
(31-35 weeks)
Term infants**: < or = 290 ng/dL
Tanner Stages**
II-III Males: 17-82 ng/dL
II-III Females: 43-180 ng/dL
IV-V Males: 57-150 ng/dL
IV-V Females: 73-220 ng/dL
**Pediatric data from J Clin Endocrinol Metab.
1991;73:674-686 and J Clin Endocrinol Metab.
1989;69;113-1136.
NOTE: Please understand the adult female reference range changes, effective 1/24/2011.
Comments:
Androstenedione may be useful in evaluating patients with androgen
excess and managing patients with congenital adrenal hyperplasia (CAH).
Methodology:
Liquid Chromatography Tandem Mass Spectrometry
CPT Code:
82157
